Resolvyx Pharmaceuticals announced promising results for patients that suffer from dry eye syndrome during Phase 2 of a new class of anti-inflammatory medications. RX-10045, as it is now called, is a resolvin compound administered as an eye drop. In a 28 day study patients reported improved symptoms and the doctors reported a statistically significant improvement in the patients dry eyes. The entire press release is available on the Resolvyx Pharmaceuticals website. This is great news for patients that suffer from dry eyes. This is one of many medications on the horizon for the pharmaceutical treatment of dry eyes.
Visit the Total Eye Care Website
An Eye Doctor Answers Now Available on Amazon.com
- January is Glaucoma Awareness Month. If you haven't been checked, now is the time! theeyedocblog.com/glaucoma-aware… 3 days ago
- Nearly 3 million Americans have glaucoma and half of those don’t even know it. Regular, dilated eye exams are the m… twitter.com/i/web/status/1… 1 week ago
- Even though we love seeing our patients, we know that nobody wants to start the year off with an eye injury! Watch… twitter.com/i/web/status/1… 3 weeks ago
January 2019 S M T W T F S « Jun 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
- Admin children computer Computer Vision contact lens Cornea dry eye dry eye syndrome Ehlers-Danlos emergency examinations eye eyecare Eye Care Eye Lids FAQ Glaucoma LASIK Low Vision Macular Degeneration Optic Nerve optometrist orthokeratology press release Refractive issues Retina Sites We like Technology video Vision